Background Since October 1997, an international standard for hepatitis C virus (HCV) nucleic acid amplification technology assay, 96/790, has been available. We compared a series of lyophilized standards with known HCV RNA concentrations against the international standard in fluorescence quantitative PCR detection. Methods A series of lyophilized sera were calibrated by ROCHE COBAS AMPLICOR HCV Monitor test against the international standard and sent to various manufacturers to analyse the samples using their own kits. Then calibration curves from the series were compared with that obtained from the external standard calibration curve with the manufacture's series.
epatitis C virus (HCV) is a common cause of chronic liver disease. HCV RNA is usually detected in serum by techniques based on sensitive polymerase chain reaction (PCR) and has become a useful tool for diagnosis and monitoring. 1, 2 Besides methods for qualitative detection of viremia, a number of procedures to quantify serum HCV RNA have been developed, including end point dilution PCR, 3 competitive PCR, 4, 5 isothermal nucleic acid amplification 6 and signal amplification of branched DNA. 7 Routine use of these techniques in a wide clinical setting is hampered by problems of specificity and sensitivity, lack of reproducibility, poor standardization and high cost. 8 Several commercially available tests, used in the last few years to quantitate serum HCV RNA levels in China, yielded conflicting quantitative results with differences of up to a factor of 10. [7] [8] [9] The first World Health Organization (WHO) international standard for HCV RNA for nucleic acid amplification technology (NAT) (96/790) was established in 1997 based on the results of an international collaborative study, and its HCV RNA content was expressed in international unit (IU). 10 Since then, calibration of working reagents has become possible and harmonization of data from individual laboratories has been feasible.
As the official Chinese medicine control laboratory, National Centre for Clinical Laboratory, Beijing, China, our reference materials already have proved to be useful in a quality control trial 11, 12 and have provided a basis for the comparison of test kits for the detection of HCV RNA since 1997. Our HCV RNA reference materials study began in 1998. In this paper, we report HCV RNA lyophilized reference material for quantitative real time PCR assay validated against the international standard. The method is based on linearity, and taking into account the detection range can be performed in a routine setting. The standard curves from commercially available assays were compared with the reference sera. The results demonstrate that a calibrated concentration of HCV RNA molecules would allow an objective and reproducible standardization of assays for the detection of HCV RNA by commercial kits.
METHODS

HCV RNA serum standard dilution
As the primary standard, we used serial dilutions of the WHO standard HCV RNA (96/790, National Institute for Biological Standards and Control, Herts, UK). The vial was reconstituted with 0.5 ml of nuclease free water, resulting in a solution that contains 10 5 IU/ml HCV RNA. The following dilution of WHO standard 96/790, were prepared by using normal HCV negative human plasma as diluent (IU/ml): 312 500, 100 000, 31 250, 10 000, 3125, 1000, 312, 100, 31, 10 and blank. Duplicate aliquots (220 µl) were used in HCM MONITOR assay. All dilutions were frozen at -70˚C until lyophilized.
HCV RNA lyophilized standard preparation
This report describes the HCV RNA references designed and prepared by the National Centre for Clinical Laboratory. The 7 references were prepared from human plasma containing HCV RNA by appropriate dilutions to approximate target levels of 10 3 to 10 6 IU/ml and one negative serum. Lyophilization was performed overnight with the vacuum chamber temperature set at -40˚C. All the lyophilized standards were stored at -20˚C before testing.
COBAS AMPLICOR HCV 2.0 assay HCV RNA levels of WHO standard HCV RNA (96/790) series dilution and the lyophilized standards were measured using the COBAS AMPLICOR HCV 2.0 assay (Roche Molecular Systems, USA) in accordance with the instructions of the manufacturer. Briefly, HCV RNA was extracted from 200 µl of serum or plasma with 400 µl of working HCV Lysis Buffer containing a known number of internal control (IC) RNA molecules. After 10 minutes of incubation at 60˚C, the RNA was precipitated with propan-2-ol (600 µl), recovered by microcentrifugation (12 500×g for 15 minutes at room temperature), washed with 1 ml of 70% ethanol and resuspended in 200 µl of HCV specimen diluent. Fifty microlitres processed specimen was added to working HCV master mix (prepared by adding HCV manganese solution to HCV Master Mix) for the RT-PCR amplification reactions. The amplification reaction contained the HCV RNA recovered from 50 µl of serum or plasma. All HCV tests amplify and detect a 244 base target sequence located in a highly conserved 5' untranslated region of the HCV genome. 13 The two amplification products, 244 bp sequences generated from HCV and internal control or quantitation standard (IC, QS) target RNA, were detected colorimetrically. Immediately upon completion of the amplification reaction, amplification products were denatured by adding 100 µl of denaturation solution to each reaction mixture. For both the qualitative and MONITOR tests, this step was performed manually in the AMPLICOR test format or automatically in the COBAS AMPLICOR test format by the COBAS AMPLICOR analyzer.
Interpretation of results
HCV RNA quantitation by COBAS
The dilutions for target and QS, that yielded the lowest signals within the linear range of the colorimetric detection assay (i.e., A 450 between 0.15 and 2.0), were identified for AMPLICOR HCV test. The AMPLICOR HCV monitor test, version 2.0, has a stated dynamic range of quantitation between 600 and 850 000 IU/ml. The absorbance for this dilution was corrected by subtracting the background absorbance (A 450 , 0.07), and the resulting corrected absorbance was multiplied by the dilution factor to determine the signal attributed to the analyte. The input HCV RNA concentration was calculated by comparing the total HCV absorbance of the sample to the total QS absorbance for the sample. After amplification and denaturation, the amplified products were serially diluted directly in separate microwells coated with HCV and QS specific probes.
Measurement of the optical density (OD) at 450 nm yielded two series of values: sample and QS. The concentration of HCV RNA in the sample was calculated by using two different approaches, namely, (1) the manufacturer's formula OD HCV ×DF HCV RNA (IU/ml) = ×(QS IU input ×200) OD HCVQS where OD is the lowest optical density value that falls between 0.15 and 2.0, DF is the dilution factor associated with the respective OD value, QS IU input is the lot specific concentration assigned to the QS and 200 is the dilution factor, and (2) in this study, we generating a standard curve by the ratio OD WHO ×DF OD WHO QS ×DF vs assigned HCV RNA content of the WHO standard, and then the concentration of the lyophilized standards by their ratio OD sample ×DF OD sample QS ×DF The standard curve were performed by the calculated value (the ratio) get from the detection vs serially diluted WHO standard, and then the concentration of the lyophilized standards can be calculated by the ratio.
Calibrating the lyophilized standards to international units
The amounts of HCV RNA in the lyophilized standards were calculated by the standard curve through its ratio (Table 1 ).
HCV RNA quantitation real time PCR assay
The lyophilized standards and the National Reference Plasma for HCV RNA were distributed to three manufacturers in China; each product was a real time PCR detection kit. All isolations and amplification reactions were performed in duplicate and the National Reference Plasma were diluted by HCV negative plasma with half-log fold of 1/3.2, 1/10, 1/32, 1/100, 1/320, 1/1000. For standardization of the real time PCR detection assay, an external standard curve ranging usually from 10 4 to 10 7 copies/ml was used.
Lyophilized standards for the calibration of real time PCR assay
A new standard curve by crossing threshold (C T ) vs log of four of the lyophilized standards (C01, C02, C04 and C06) which were generated from each manufacture assay was obtained ( Table 2) . Coefficients of variation (CV) vary from 58.62% to 76.47% for dilutions of National Standards with quantitative values determined by the manufacture's standard curve. The results from our calibrated standard curve were more comparable with CVs varying from 6.00% to 11.54 % ( Table 3) . RESULTS
The standard curve generated from WHO standard DISCUSSION
In our study, the ratio is calculated by dividing the total OD generated from the WHO standards series by the total OD of QS, and then our standard curve generated from that ratio and the concentration of the WHO standards series ( Fig.) .
PCR products may be quantitated by generating a standard curve or quantitated relative to a control gene. Real time PCR quantitation based on a standard curve may utilize plasmid DNA or other forms of DNA 11.54 in which the absolute concentration of each standard is known. One must be sure, however, that the efficiency of PCR is the same for the standards as that of the "unknown" samples. Performing PCR from purified targets can in some cases be more efficient than that observed with complex nucleic acid mixtures. A limitation for any current HCV RNA assay in China is that it is impossible to compare assay performance and to determine which assays are most accurate and sensitive. The various assays employ different formats; have different sensitivities and report results in different units of measurements (e.g., copies and genome equivalents). Additionally, assays that use the same unit of measurement give different results for the same sample; thus, copies measured by one assay format are not equivalent to copies measuredby another assay format. Furthermore, the viral load cutoff used to predict response to therapy is assay specific. [13] [14] [15] These limitations can be overcome by adopting a commonly accepted standard of measurement, the international unit. By international agreement, 100 000 IU is defined as the amount of virus in 1 ml of the first WHO International Standard for Nucleic Acid Amplification Technology Assays for HCV RNA (WHO Standard 96/790), which is distributed in vials containing 50 000 IU per vial. However, the supply of the WHO international standard is limited. Thus, working standards were created for performing routine calibrations. The concentration of HCV in each of the lyophilized standards can now be expressed in IU/ml enabling the reagents to be used for validation and calibration. [16] [17] [18] [19] Recognizing the importance of a common unit of measurement, our tests are calibrated with standards containing a known quantity of international units and linearity of the standard calibration curve was good enough for quantitative detection (R 2 =0.9874, 0.9853 and 0.9816). All results in the half log dilutions quantitative tests and the analytical sensitivity of the qualitative tests are now reported in international units per millilitre. As all the manufacturers in China have adopted the international unit as the unit of measurement, comparisons of assay sensitivity, dynamic range and other performance characteristics results from different laboratories should be directly comparable.
The broad linear range of a real time PCR test makes it well suited for predicting and monitoring the response to therapy. Future studies that use international units per millilitre as a standardized reporting format should identify a prognostic cutoff. It should be noted, however, that the prognostic value of pretreatment viral load may diminish with the availability of more potent antiviral treatment regimens since reasonably high sustained response rates can be achieved in patients with high viral loads.
In summary, our method provides lyophilized standards that offer several advantages over the existing working standard. Firstly, it uses plasma to monitor the integrity of sample extraction, reverse transcription and amplification and thereby, help eliminate the difference between efficiency of standards and samples. Secondly, the TaqMan HCV quantitation assay was calibrated in IU/ml as recommended by WHO. Lastly, lyophilized standards are stable for several years and shipped to laboratories at room temperature, so, they can be easily used daily.
